Apr 26 |
HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer Received by Takeda
|
Apr 26 |
Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer
|
Apr 25 |
Takeda said to have left industry trade group BIO
|
Apr 25 |
All You Need to Know About Takeda Pharmaceutical Co. (TAK) Rating Upgrade to Strong Buy
|
Apr 25 |
TAK or CTLT: Which Is the Better Value Stock Right Now?
|
Apr 25 |
20 Fastest Growing Health Tech Companies in the World
|
Apr 25 |
New Strong Buy Stocks for April 25th
|
Apr 25 |
Best Value Stocks to Buy for April 25th
|
Apr 25 |
Best Income Stocks to Buy for April 25th
|
Apr 23 |
Neurocrine succeeds in mid-stage trial for Takeda-partnered depression drug
|